Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (BEIGF) Assets Average (2016 - 2025)

Historic Assets Average for BeOne Medicines (BEIGF) over the last 10 years, with Q3 2025 value amounting to $7.0 billion.

  • BeOne Medicines' Assets Average rose 2068.73% to $7.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 billion, marking a year-over-year increase of 2068.73%. This contributed to the annual value of $5.9 billion for FY2024, which is 389.61% up from last year.
  • As of Q3 2025, BeOne Medicines' Assets Average stood at $7.0 billion, which was up 2068.73% from $6.1 billion recorded in Q2 2025.
  • Over the past 5 years, BeOne Medicines' Assets Average peaked at $8.3 billion during Q1 2022, and registered a low of $5.4 billion during Q3 2021.
  • Over the past 5 years, BeOne Medicines' median Assets Average value was $5.8 billion (recorded in 2023), while the average stood at $6.2 billion.
  • Per our database at Business Quant, BeOne Medicines' Assets Average surged by 10110.5% in 2021 and then tumbled by 3091.73% in 2023.
  • Over the past 5 years, BeOne Medicines' Assets Average (Quarter) stood at $6.9 billion in 2021, then decreased by 11.68% to $6.1 billion in 2022, then dropped by 7.18% to $5.7 billion in 2023, then rose by 3.72% to $5.9 billion in 2024, then grew by 18.54% to $7.0 billion in 2025.
  • Its Assets Average stands at $7.0 billion for Q3 2025, versus $6.1 billion for Q2 2025 and $5.9 billion for Q1 2025.